Studies of glucocorticord resistance in chronic lymphocytic leukaemia
Glucocorticoids represent an important component of modern treatment regimens for patients with fludarabine-refractory or TP53-defective chronic lymphocytic leukaemia. However, not all patients respond to GC therapy. This in-vitro study / investigated-the molecular mechanisms responsible for GC resi...
Main Author: | |
---|---|
Published: |
University of Liverpool
2012
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.569547 |